In vitro correlate of immunity in a rabbit model of inhalational anthrax

Vaccine

Volumn 19, Issue 32, 2001, Pages 4768-4773

  Pitt, M L M ^a   Little, S F ^a   Ivins, B E ^a   Fellows, P ^a   Barth, J ^a   Hewetson, J ^a   Gibbs, P ^a   Dertzbaugh, M ^a   Friedlander, A M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax; Bacillus anthracis; Serological correlate

Indexed keywords

ANTHRAX VACCINE; ANTIGEN; BUFFER; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PHOSPHATE; SODIUM CHLORIDE; TOXIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY BLOOD LEVEL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; CONTROLLED STUDY; DEATH; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; IMMUNOASSAY; INOCULATION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; SURVIVAL;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL CAPSULES; BACTERIAL TOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MALE; MAMMALS; MODELS, ANIMAL; NEUTRALIZATION TESTS; RABBITS; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; SPORES, BACTERIAL; VIRULENCE;

EID: 0035860571     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00234-1     Document Type: Article

References (40)

1. A history of anthax
2. Anthrax: Clinical features, pathogenesis, and potential biological warfare threat
3. Inhalation anthrax
4. The Sverdlovsk anthrax outbreak of 1979
5. Iraq's biological weapons. The past as future?
6. Demonstration of a capsule plasmid in Bacillus anthracis
7. Evidence for plasmid-mediated toxin production in Bacillus anthracis
8. Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis
9. Large-scale production of protective antigen of B. anthracis anaerobic cultures
10. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs
11. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys
12. Comparison of the efficacy of purified protective antigen and MDPH (anthrax vaccine adsorbed) to protect non-human primates from inhalation anthrax
13. Comparative efficacy of a recombinant protective antigen vaccine against inhalation anthrax in guinea pigs, rabbits, and rhesus monkeys
14. The critical orifice liquid impinger as a sampler for bacterial aerosols
15. The Collison nebulizer, description, performance and applications
16. Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis
17. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
18. Pathogenesis of respiratory anthrax in Macaca mulatta
19. Pathology of experimental respiratory anthrax in Macaca mulatta
20. Pathology of anthrax infection in animal hosts
21. Pathology of experimental inhalation anthrax in the rhesus monkey
22. Differences in susceptibility of inbred mice to Bacillus anthracis
23. Resistance to the Sterne strain of B. anthracis: Phagocytic cell responses of resistant and susceptible mice
24. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice
25. Quantitative assay for crude anthrax toxins
26. Value of field data for extrapolation in anthrax
27. The pathogenesis of anthrax following the administration of spores by the respiratory route
28. Pathogenesis as related to physiological state of anthrax spore and cell
29. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants
30. Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs
31. Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers
32. Adjuvants in perspective
33. Immunologic adjuvants for modern vaccine formulations
34. Cutaneous anthrax: A pathologic study with clinical correlation
35. The role of antitoxin in immunity to anthrax
36. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation
37. Efficacy in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis strains of diverse geographical origin
38. Protective efficacy of anthrax vaccine against parenteral challenge: A guinea pig model
39. Vaccination against anthrax with attenuated recombinant strains of bacillus anthracis that produce protective antigen
40. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs